Dupont Capital Management Corp acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 1,570 shares of the medical research company’s stock, valued at approximately $101,000.
A number of other institutional investors also recently added to or reduced their stakes in the business. Advisor Group Inc. increased its stake in Agilent Technologies by 0.3% in the 2nd quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock valued at $235,000 after buying an additional 10 shares during the period. Bronfman E.L. Rothschild L.P. increased its stake in shares of Agilent Technologies by 0.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock worth $276,000 after purchasing an additional 35 shares during the last quarter. Veritable L.P. increased its stake in shares of Agilent Technologies by 0.4% during the 2nd quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after purchasing an additional 40 shares during the last quarter. Balentine LLC increased its stake in shares of Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares during the last quarter. Finally, Kingfisher Capital LLC increased its stake in shares of Agilent Technologies by 0.3% during the 2nd quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock worth $1,343,000 after purchasing an additional 58 shares during the last quarter.
Shares of Agilent Technologies, Inc. (NYSE:A) opened at $67.13 on Tuesday. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $68.67. The firm has a market cap of $21,501.33, a price-to-earnings ratio of 29.17, a price-to-earnings-growth ratio of 2.62 and a beta of 1.27.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm earned $0.49 EPS. The business’s revenue was up 6.7% on a year-over-year basis. equities research analysts predict that Agilent Technologies, Inc. will post 2.32 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd were issued a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend was Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 27.32%.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/14/dupont-capital-management-corp-takes-101000-position-in-agilent-technologies-inc-a.html.
Several research analysts have recently commented on the stock. BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Janney Montgomery Scott upped their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $70.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 16th. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $68.00 price objective on shares of Agilent Technologies in a report on Tuesday, September 26th. Finally, Bank of America Corporation upped their price objective on shares of Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 16th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $66.70.
In other news, insider Mark Doak sold 12,421 shares of the firm’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $63.63, for a total transaction of $286,335.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 165,720 shares of company stock valued at $10,488,739.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.